Evotec (EVO) vs Silence Therapeutics Plc American Depository Share (SLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Silence Therapeutics Plc American Depository Share (SLN) has outperformed Evotec (EVO) over the past year, gaining 91.1% versus a loss of 58.9%. Over five years, SLN leads with a -55.0% price change compared with -92.9% for EVO. Silence Therapeutics Plc American Depository Share is the larger company by market cap ($610.4 million vs $572.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVO | SLN |
|---|---|---|
| Share price | $1.61 | $9.82 |
| Market cap | $572.18M | $610.35M |
| 1-day change | -1.23% | -0.10% |
| YTD return | -47.73% | +61.51% |
| 1-year return | -58.93% | +91.05% |
| 5-year return | -92.87% | -55.00% |
| EPS (TTM) | $-0.64 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.27 | $17.58 |
| 52-week low | $1.50 | $4.19 |
| Distance from 52-week high | -62.30% | -44.13% |
| Average volume | 102.81K | 1.11M |
| Shares outstanding | 355.39M | 62.15M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SLN has outperformed EVO by 150.0 percentage points over the past year.
EVO vs SLN FAQ
Which is bigger, Evotec or Silence Therapeutics Plc American Depository Share?
Silence Therapeutics Plc American Depository Share (SLN) is larger, with a market capitalization of $610.35M compared with $572.18M for Evotec (EVO).
Which stock has performed better over the past year, EVO or SLN?
SLN returned +91.05% over the past 12 months, compared with -58.93% for EVO (price return, excluding dividends). Past performance does not predict future results.
Are Evotec and Silence Therapeutics Plc American Depository Share in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.